• Mashup Score: 0
    Program Planner - 1 year(s) ago

    Program Planner One fine body�

    Tweet Tweets with this article
    • Pneumonitis incidence in Pts w/ NSCLC Tx'd w/ immunotherapy or chemotherapy in clinical trials and real-world data [Apr 27, 2020] Liu et al. #AACR20 CT086 - VCTPL08 Session https://t.co/VkpILtOd12 #lcsm #irAE #ImmunoOnc @Syapse @US_FDA @Aurora_Cancer https://t.co/B2okjijdBv

  • Mashup Score: 1
    Program Planner - 1 year(s) ago

    Program Planner One fine body�

    Tweet Tweets with this article
    • Pneumonitis incidence in Pts w/ NSCLC Tx'd w/ immunotherapy or chemotherapy in clinical trials and real-world data [Apr 27, 2020] Liu et al. @TDBrownMD #AACR20 CT086 - VCTPL08 Session https://t.co/VkpILtOd12 #lcsm #irAE #ImmunoOnc @Syapse @US_FDA @Aurora_Cancer

  • Mashup Score: 0
    Program Planner - 2 year(s) ago

    Program Planner One fine body�

    Tweet Tweets with this article
    • Pneumonitis incidence in Pts w/ NSCLC Tx'd w/ immunotherapy or chemotherapy in clinical trials and real-world data [Apr 27, 2020] Liu et al. #AACR20 CT086 - VCTPL08 Session https://t.co/VkpILtNFbu #lcsm #irAE #ImmunoOnc @Syapse @US_FDA @Aurora_Cancer https://t.co/V7V1yqbWsG

  • Mashup Score: 1
    Program Planner - 2 year(s) ago

    Program Planner One fine body�

    Tweet Tweets with this article
    • Pneumonitis incidence in non-small cell lung cancer treated with immunotherapy or chemotherapy in clinical trials and real-world data [Apr 27, 2020] Liu et al. #AACR20 CT086 - VCTPL08 - Lung Cancer Targeted Therapy https://t.co/VkpILtNFbu #lcsm #irAE @Syapse @Aurora_Cancer

  • Mashup Score: 1
    Program Planner - 2 year(s) ago

    Program Planner One fine body�

    Tweet Tweets with this article
    • Pneumonitis incidence in Pts w/ NSCLC Tx'd w/ immunotherapy or chemotherapy in clinical trials and real-world data [Apr 27, 2020] Liu et al. #AACR20 CT086 - VCTPL08 Session https://t.co/VkpILtNFbu #lcsm #irAE #ImmunoOnc @Syapse @US_FDA @Aurora_Cancer https://t.co/LiqfY841uQ

  • Mashup Score: 0
    Program Planner - 2 year(s) ago

    One fine body?

    Tweet Tweets with this article
    • Pneumonitis incidence in Pts w/ NSCLC Tx'd w/ immunotherapy or chemotherapy in clinical trials and real-world data [Apr 27, 2020] Liu et al. #AACR20 CT086 - VCTPL08 Session https://t.co/VkpILtNFbu #lcsm #irAE #ImmunoOnc @Syapse @US_FDA @Aurora_Cancer https://t.co/pk3Bxp9AjK

  • Mashup Score: 0
    Program Planner - 2 year(s) ago

    One fine body?

    Tweet Tweets with this article
    • Pneumonitis incidence in NSCLC Tx'd w/ immunotherapy or chemotherapy in clinical trials & real-world data (RWD) [Apr 27, 2020] Liu et al. #AACR20 CT086 https://t.co/VkpILtNFbu #lcsm #irAE #caxtx @Syapse Similar magnitude b/w @FDAOncology vs @Aurora_Cancer RWD https://t.co/dB9fIe14bF

  • Mashup Score: 0
    Program Planner - 2 year(s) ago

    One fine body?

    Tweet Tweets with this article
    • Pneumonitis incidence in Pts w/ NSCLC Tx'd w/ immunotherapy or chemotherapy in clinical trials and real-world data [Apr 27, 2020] Liu et al. #AACR20 CT086 - VCTPL08 Session https://t.co/VkpILtNFbu #lcsm #irAE #ImmunoOnc @Syapse @US_FDA @Aurora_Cancer https://t.co/0zov81OnzR

  • Mashup Score: 1
    Program Planner - 3 year(s) ago

    One fine body?

    Tweet Tweets with this article
    • Pneumonitis incidence in NSCLC Tx'd w/ immunotherapy or chemotherapy in clinical trials & real-world data (RWD) [Apr 27, 2020] Liu et al. #AACR20 CT086 https://t.co/VkpILtNFbu #lcsm #irAE #caxtx @Syapse Similar magnitude b/w @FDAOncology vs @Aurora_Cancer RWD https://t.co/4BjYw0TKby